MediWound Prices $15M Bought Deal at $12.50, a Premium to the $11.78 Close
MDWD is trading near its 52-week low of $11.8 (0.2% below the low).
Summary
MediWound sold 1,200,000 ordinary shares to H.C. Wainwright at $12.50 apiece for roughly $15 million gross, with a 30-day option for another 180,000 shares. The deal prices above the $11.78 last close, so the company is not paying a discount to get the money in — unusual for a small-cap raise and a sign the book was covered. The dilution is real but modest: about 1.2 million new shares against a company trading near its 52-week low of $11.80. Proceeds go to working capital and general corporate purposes, not a named program. Context matters here: Q2 revenue fell 46% to $3.1 million and first-half cash burn ran about $20 million, so this raise buys runway rather than funding growth. Closing is expected on or about November 5, 2026, subject to customary conditions.
At the time of this announcement, MDWD was trading at $11.78 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $172.9M. The 52-week trading range was $11.80 to $19.70. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.